Gilead Beats Antitrust Suit Over HIV Drug Patents
AIDS Healthcare Foundation Inc. can't invalidate five patents for HIV treatments or support antitrust claims against Gilead Sciences Inc., a California federal judge said Wednesday as he dismissed the case in...To view the full article, register now.
Already a subscriber? Click here to view full article